Diamond-Blackfan anemia: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
|||
| Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Erythrogenesis imperfecta; congenital pure red cell aplasia | {{SK}} Erythrogenesis imperfecta; congenital pure red cell aplasia, hereditary pure red cell aplasia, familial pure red cell aplasia | ||
==[[Diamond-Blackfan anemia overview|Overview]]== | ==[[Diamond-Blackfan anemia overview|Overview]]== | ||
Revision as of 18:13, 15 February 2015
| Diamond-Blackfan anemia | |
| ICD-10 | D61.0 |
|---|---|
| ICD-9 | 284.01 |
| OMIM | 105650 |
| DiseasesDB | 29062 |
| MeSH | D029503 |
|
Diamond-Blackfan anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diamond-Blackfan anemia On the Web |
|
American Roentgen Ray Society Images of Diamond-Blackfan anemia |
|
Risk calculators and risk factors for Diamond-Blackfan anemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Erythrogenesis imperfecta; congenital pure red cell aplasia, hereditary pure red cell aplasia, familial pure red cell aplasia
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Diamond-Blackfan anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies